Abstract: The present invention encompasses pharmaceutical formulations comprising a biphasic mixture which comprises a glucagon like peptide (GLP-1) compound in a solid phase and an insulin in a solution phase.

Abstract: The present invention encompasses a method of treating a disease by maintaining chronic steady state serum levels of a GLP-1 compound within a specified range.

Abstract: The invention includes systems, methods, computer program products, and combinations and sub-combinations thereof for enabling channels specific to a user's interest (as well as other objects) to be loaded on mobile devices (as well as other types of devices), and for users of mobile devices to operate with such channels on their mobile devices in an interactive manner while in an off-line mode.

Abstract: The invention relates to a method and a device for the dynamic optimization of business processes, the business process instances of a business process being managed by a workflow management computer system. The invention is in particular characterized by collecting, investigating and storing parameters, processing data and result data, and subsequently optimizing business processes on the basis of stored information by identifying a business process instance having propitious result data, modifying the parameters of said instance and subsequent verification of such modification. The invention is further characterized by the use of genetic algorithms and orthogonal matrices for the modification of the parameters of the identified business process instance with propitious result data. The invention is suitable for being used in the process optimization in production engineering and plant engineering and in process optimization in the service field.

Abstract: The invention as disclosed herein teaches apparatus whereby the instantaneous dynamic static pressure and the steady-state static pressure may be simultaneously measured within a supersonic or subsonic gaseous fluid flow field. The dynamic static pressure is measured by an electronic transducer and the steady-state static pressure is measured by pneumatic means.

Abstract: The invention relates to the use of estriol as the sole active ingredient for the production of a transdermal medicament which continuously releases the active ingredient for the treatment of climacteric osteoporosis. It has been shown according to the invention that estriol, which has up until now been thought ineffective for the treatment of climacteric osteoporosis, develops strong anti-osteoporotic effectiveness upon continuous transdermal application.

Abstract: A system for controlling unauthorized access to information distributed to users and, more particularly, for controlling unauthorized access to software distributed to users is provided. One method utilizing the system of the present invention enables the software to be encrypted using a single encryption key and to be decrypted using a multiplicity of "decryption" keys, each of which is unique to a particular user. The "decryption" keys are the products of numeric representations of identifying information relating to users and unique user keys generated using the numeric representations and a "true" decryption key. Since each user receives a unique user key and both the numeric representation and the user key are generated using the identifying information, if the user reveals the numeric representation and the user key (or the product of the numeric representation and the user key), the numeric representation and the user key can be traced to the user who revealed them.

Abstract: A plurality of elements with dimensions forming a series of the FIBONACCI-type having a relationship of 1/2 .+-. 1/2 .sqroot.5. Such elements are suitable for economizing storage space and manufacturing costs as only a limited number of different sizes are to be kept in stock.

Abstract: Paper coating compositions with finely divided pigment, optical brightener and a binder containing a copolymer of from 5 to 30% by weight of mono-olefinically unsaturated carboxylic acids, from 5 to 30% by weight of mono-olefinically unsaturated monomers containing basic nitrogen atoms and from 50 to 80% by weight of other olefinically unsaturated monomers which, when polymerized alone, give water-insoluble homopolymers and cause virtually no reduction in the effect of conventional optical brighteners even in the absence of casein or carboxymethyl cellulose.